Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for James B Weissman. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at James B Weissman har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
Director 8.390
US:DRNA / Dicerna Pharmaceuticals Inc Chief Operating Officer & EVP 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af James B Weissman. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af James B Weissman som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-07-26 2024-07-24 4 TBIO Telesis Bio Inc.
Common Stock
A - Award 8.390 8.390
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -68.100 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -121.300 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -75.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -111.800 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -180.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -105.000 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -33.999 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
D - Sale to Issuer -11.879 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
D - Sale to Issuer -11.325 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
D - Sale to Issuer -25.950 0 -100,00
2021-12-29 2021-12-28 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
U - Other -18.100 0 -100,00 38,25 -692.325
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
M - Exercise -3.775 11.325 -25,00
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -1.675 18.100 -8,47 38,05 -63.734 688.705
2021-12-17 2021-12-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 3.775 19.775 23,59
2021-07-08 2021-07-06 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -30.000 33.999 -46,88
2021-07-08 2021-07-06 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -30.000 16.000 -65,22 39,09 -1.172.700 625.440
2021-07-08 2021-07-06 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 30.000 46.000 187,50 9,09 272.700 418.140
2021-04-20 2021-04-16 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.904 16.000 -23,46 29,99 -147.071 479.840
2021-02-08 2021-02-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -7.156 20.904 -25,50 26,99 -193.140 564.199
2021-01-13 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -5.808 28.060 -17,15 24,08 -139.868 675.741
2021-01-12 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 68.100 68.100
2021-01-12 2021-01-12 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
A - Award 15.100 15.100
2021-01-12 2021-01-11 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -3.800 33.868 -10,09 23,99 -91.162 812.493
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
M - Exercise -8.650 25.950 -25,00
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -2.842 37.668 -7,02 23,29 -66.190 877.288
2021-01-12 2021-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.650 40.510 27,15
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 0 -100,00
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 31.860 -12,04 25,21 -109.903 803.098
2020-12-03 2020-12-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 36.220 13,68 3,42 14.911 123.872
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 4.360 -50,00
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 31.860 -12,04 20,95 -91.333 667.403
2020-11-03 2020-11-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 36.220 13,68 3,42 14.911 123.872
2020-10-22 2020-10-20 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10.000 11.879 -45,71
2020-10-22 2020-10-20 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10.000 31.860 45,75 2,97 29.700 94.624
2020-10-19 2020-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -8.720 8.720 -50,00
2020-10-19 2020-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.720 21.860 -28,52 20,20 -176.144 441.572
2020-10-19 2020-10-15 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 8.720 30.580 39,89 3,42 29.822 104.584
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 25.980 -14,37
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.307 21.860 -5,64 26,87 -35.116 587.330
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -3.053 23.167 -11,64 26,39 -80.563 611.333
2020-09-04 2020-07-01 4/A DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -259 17.440 -1,46
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.101 21.879 -15,79
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.432 21.860 -6,15 22,80 -32.649 498.393
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -2.928 23.292 -11,17 22,31 -65.330 519.691
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 259 26.220 1,00 3,42 886 89.672
2020-08-05 2020-08-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.101 25.961 18,76 2,97 12.180 77.104
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 25.980 -14,37
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.307 21.860 -5,64 26,87 -35.116 587.330
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -3.053 23.167 -11,64 26,39 -80.563 611.333
2020-07-06 2020-07-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 30.340 -12,56
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 21,06 -91.807 460.299
2020-06-02 2020-06-01 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-05-06 2020-05-04 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise 4.360 34.700 14,37
2020-05-06 2020-05-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 20,20 -88.072 441.572
2020-05-06 2020-05-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-04-14 2020-04-13 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 39.060 -10,04
2020-04-14 2020-04-13 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 20,20 -88.072 441.572
2020-04-14 2020-04-13 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 43.420 -9,13
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 20,61 -89.854 450.506
2020-03-03 2020-03-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-02-04 2020-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.360 47.780 -8,36
2020-02-04 2020-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 20,20 -88.072 441.572
2020-02-04 2020-02-03 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.360 26.220 19,95 2,97 12.949 77.873
2020-01-10 2020-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 121.300 121.300
2020-01-10 2020-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Restricted Stock Units
A - Award 34.600 34.600
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -2.860 52.140 -5,20
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -1.500 0 -100,00
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -4.360 21.860 -16,63 21,88 -95.376 478.194
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 2.860 26.220 12,24 2,97 8.494 77.873
2020-01-03 2020-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 1.500 23.360 6,86 3,42 5.130 79.891
2019-12-19 2019-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -11.001 63.999 -14,67
2019-12-19 2019-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
F - Taxes -3.845 21.860 -14,96 26,01 -100.008 568.579
2019-12-19 2019-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 11.001 25.705 74,82 9,09 99.999 233.658
2019-12-03 2019-12-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20.000 55.000 -26,67
2019-12-03 2019-12-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20.000 14.704 -57,63 26,00 -520.000 382.304
2019-12-03 2019-12-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20.000 34.704 136,02 2,97 59.400 103.071
2019-11-20 2019-11-19 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2019-11-20 2019-11-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20.000 14.704 -57,63 24,00 -480.000 352.896
2019-11-20 2019-11-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20.000 34.704 136,02 3,42 68.400 118.688
2019-11-20 2019-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20.000 20.000 -50,00
2019-11-20 2019-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20.000 14.704 -57,63 22,00 -440.000 323.488
2019-11-20 2019-11-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20.000 34.704 136,02 3,42 68.400 118.688
2019-11-15 2019-11-14 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -20.000 40.000 -33,33
2019-11-15 2019-11-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -20.000 14.704 -57,63 20,00 -400.000 294.080
2019-11-15 2019-11-14 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 20.000 34.704 136,02 3,42 68.400 118.688
2019-11-01 2019-10-31 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -15.000 17.699 -45,87
2019-11-01 2019-10-31 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -15.000 14.704 -50,50 18,00 -270.000 264.672
2019-11-01 2019-10-31 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 15.000 29.704 102,01 3,42 51.300 101.588
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -4.104 60.000 -6,40
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -800 0 -100,00
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 4.104 14.704 38,72 3,42 14.036 50.288
2019-10-18 2019-10-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 800 10.600 8,16 3,42 2.736 36.252
2019-08-23 2019-08-23 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -14.680 9.800 -59,97 13,07 -191.832 128.062
2019-04-04 2019-04-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -15.000 32.699 -31,45
2019-04-04 2019-04-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -15.000 24.480 -37,99 15,00 -225.000 367.200
2019-04-04 2019-04-02 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 15.000 39.480 61,27 3,42 51.300 135.022
2019-01-04 2019-01-02 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 180.000 180.000
2018-09-06 2018-09-05 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -2.301 47.699 -4,60
2018-09-06 2018-09-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -2.301 24.480 -8,59 17,50 -40.268 428.400
2018-09-06 2018-09-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 2.301 26.781 9,40 3,42 7.869 91.591
2018-08-20 2018-08-17 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -14.680 64.104 -18,63
2018-08-20 2018-08-17 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 14.680 24.480 149,80 3,42 50.206 83.722
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
M - Exercise -10.000 50.000 -16,67
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -10.000 9.800 -50,51 15,00 -150.000 147.000
2018-05-11 2018-05-09 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 10.000 19.800 102,04 3,42 34.200 67.716
2018-04-24 2018-04-20 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -8.965 9.800 -47,78 13,00 -116.545 127.400
2018-03-21 2018-03-19 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
S - Sale X -1.035 18.765 -5,23 13,00 -13.455 243.945
2018-01-08 2018-01-04 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 105.000 105.000
2017-01-05 2017-01-03 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75.000 75.000
2016-05-16 2016-05-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 4.170 19.800 26,68 3,29 13.719 65.140
2016-05-16 2016-05-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 530 15.630 3,51 3,29 1.744 51.418
2016-05-16 2016-05-12 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 300 15.100 2,03 3,24 972 48.922
2016-01-12 2016-01-08 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75.000 75.000
2015-01-13 2015-01-09 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy)
A - Award 75.000 75.000
2014-04-18 2014-04-16 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 111.800 111.800
2014-02-20 2014-01-29 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
P - Purchase 1.000 13.116 8,25 15,00 15.000 196.740
2014-02-20 2014-01-27 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -67 800 -7,73
2014-02-20 2014-01-27 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -11.216 78.784 -12,46
2014-02-20 2014-01-27 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 11.283 12.116 1.354,50 3,24 36.557 39.256
2014-02-20 2013-11-11 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -100 1.500 -6,25
2014-02-20 2013-11-11 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
M - Exercise -733 867 -45,81
2014-02-20 2013-11-05 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
M - Exercise 833 833 3,42 2.849 2.849
2014-02-20 2013-09-24 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 90.000 90.000
2014-02-20 2013-09-24 4 DRNA Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 60.000 60.000
2014-01-29 3 DRNA Dicerna Pharmaceuticals Inc
Common Stock
12.116
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)